Roundup

Five things for pharma marketers to know: Friday, March 27, 2020

By

Alison Kanski

Publish Date March 27, 2020

Hospitals to receive $100 billion in emergency funds; COVID-19 cases surpass 500,000 worldwide; BMS wins approval for multiple sclerosis drug.

Five things for pharma marketers to know: Thursday, March 26, 2020

By

Carrie Gavit

Publish Date March 26, 2020

WHO deems virus “Public Enemy No. 1;” NYC closes some streets to cars to allow for social distancing; Ventilator demand is 10 times what’s available.

Five things for pharma marketers to know: Wednesday, March 25, 2020

By

Alison Kanski

Publish Date March 25, 2020

U.S. may become coronavirus epicenter; ASCO moves conference online; Many drug trials have been postponed due to COVID-19.

Five things for pharma marketers to know: Tuesday, March 24, 2020

By

Alison Kanski

Publish Date March 24, 2020

Researchers begin testing HIV drug in COVID-19 patients; Amazon will pick up and deliver testing kits in Seattle; Gilead suspends requests for coronavirus experimental treatment.

Five things for pharma marketers to know: Monday, March 23, 2020

By

Alison Kanski

Publish Date March 23, 2020

Labs facing testing supplies shortage; Coronavirus is affecting drug studies; How countries are responding to the coronavirus.

Five things for pharma marketers to know: Friday, March 20, 2020

By

Alison Kanski

Publish Date March 20, 2020

J&J manufacturing Tylenol at maximum capacity; CDC messaging appears sidelined by White House during the outbreak; Bayer donates three million tablets to help COVID-19 response.

Five things for pharma marketers to know: Thursday, March 19, 2020

By

Carrie Gavit

Publish Date March 19, 2020

Trump invokes emergency powers for medical supplies shortage; Younger people may experience serious health risks from COVID-19; #LetsFlattenTheCurve: An initiative to encourage social distancing.

Five things for pharma marketers to know: Wednesday, March 18, 2020

By

Alison Kanski

Publish Date March 18, 2020

President Trump lifts telehealth restrictions; Researchers estimate lower death rate from COVID-19, Pfizer to co-develop COVID-19 treatment with BioNTech.

Five things for pharma marketers to know: Tuesday, March 17, 2020

By

Alison Kanski

Publish Date March 17, 2020

Drugmakers begin COVID-19 trials; Trump issues guidelines to stop coronavirus spread; Verily launches website to screen people who may have the virus.

Five things for pharma marketers to know: Wednesday, March 18, 2020

By

Alison Kanski

Publish Date March 17, 2020

President Trump lifts telehealth restrictions; Researchers estimate lower death rate from COVID-19, Pfizer to co-develop coronavirus treatment with BioNTech.

Five things for pharma marketers to know: Monday, March 16, 2020

By

Alison Kanski

Publish Date March 16, 2020

MM&M announced 2020 Hall of Femme honorees; Today is the deadline to submit for the MM&M Madness bracket; Trump declares national state of emergency due to coronavirus.

Five things for pharma marketers to know: Friday, March 13, 2020

By

Alison Kanski

Publish Date March 13, 2020

Juul cofounder to exit; Study determines incubation period for COVID-19; Congress struggles to agree on proper coronavirus response.

Five things for pharma marketers to know: Thursday, March 12, 2020

By

Carrie Gavit

Publish Date March 12, 2020

White House tells health officials coronavirus meetings are classified; MM&M Madness launches social media campaign bracket; Americans’ concern about COVID-19 grows.

Five things for pharma marketers to know: Wednesday, March 11, 2020

By

Alison Kanski

Publish Date March 11, 2020

New York opioid trial postponed; FDA warns seven companies for coronavirus claims; New York calls in National Guard for virus containment.

Five things for pharma marketers to know: Tuesday, March 10, 2020

By

Alison Kanski

Publish Date March 10, 2020

New rules expand how health data can be shared; Cruise ship with coronavirus cases docks in California; CVS offers free medication delivery, no cost telemedicine amid outbreak.